GlassScriptPhysician profile
Elaine L Chen
NPI 1962968032
$12,435.62
in general payments reported to CMS, 2019-2025
61 companies · $3,810 in 2025
The $3,810 reported for 2025 was more than what 97% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,706 · 2022: $2,357 · 2023: $2,161 · 2024: $2,402 · 2025: $3,810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,022 · Consulting Fee: $350.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,022.33 |
| Consulting Fee | $350.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,531.82 | 2021-2025 | |
| Ucb, INC. | $1,395.41 | 2021-2025 | Fintepla, Zilbrysq, Rystiggo |
| Jazz Pharmaceuticals INC. | $834.76 | 2021-2025 | |
| Harmony Biosciences LLC | $665.60 | 2021-2025 | Wakix |
| Alexion Pharmaceuticals, INC. | $665.57 | 2021-2025 | Ultomiris |
| Teva Pharmaceuticals USA, INC. | $560.44 | 2022-2025 | Austedo Xr, Austedo Xr, Austedo |
| Avadel Cns Pharmaceuticals, LLC | $527.82 | 2023-2025 | Lumryz |
| Inspire Medical Systems, INC. | $472.29 | 2024-2025 | Inspire |
| Lilly USA, LLC | $425.90 | 2021-2025 | Emgality, Kisunla, Amyvid |
| Axsome Therapeutics, INC. | $372.16 | 2023-2025 | Sunosi, Symbravo |
| Pfizer INC. | $358.24 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $324.58 | 2021-2022 | |
| Celgene Corporation | $323.42 | 2021-2025 | Zeposia |
| Biogen, INC. | $305.94 | 2021-2025 | Skyclarys, Spinraza, Vumerity |
| Lundbeck LLC | $273.73 | 2021-2025 | Vyepti |
Show all 61 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaine Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.